Chlortalidone/Valsartan

氯噻酮/缬沙坦

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChlortalidone/Valsartan
Drug Alias NameChlortalidone+valsartan氯噻酮+缬沙坦缬沙坦+氯噻酮Valsartan+ChlorthalidoneValsartan/Chlorthalidone +[6] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes ValsartanChlorthalidone
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFarma De Colombia Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFarma De Colombia Sa
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A